Logo image of RDI

READING INTERNATIONAL INC-A (RDI) Stock Fundamental Analysis

NASDAQ:RDI - Nasdaq - US7554081015 - Common Stock - Currency: USD

1.33  0 (0%)

After market: 1.24 -0.09 (-6.77%)

Fundamental Rating

1

Overall RDI gets a fundamental rating of 1 out of 10. We evaluated RDI against 72 industry peers in the Entertainment industry. RDI has a bad profitability rating. Also its financial health evaluation is rather negative. RDI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RDI had negative earnings in the past year.
RDI had a negative operating cash flow in the past year.
In the past 5 years RDI reported 4 times negative net income.
In the past 5 years RDI always reported negative operating cash flow.
RDI Yearly Net Income VS EBIT VS OCF VS FCFRDI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

RDI has a Return On Assets (-6.08%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.08%
ROE N/A
ROIC N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDI Yearly ROA, ROE, ROICRDI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

RDI has a Gross Margin of 10.43%. This is amonst the worse of the industry: RDI underperforms 80.56% of its industry peers.
RDI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RDI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
RDI Yearly Profit, Operating, Gross MarginsRDI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

0

2. Health

2.1 Basic Checks

RDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDI has more shares outstanding
The number of shares outstanding for RDI has been increased compared to 5 years ago.
Compared to 1 year ago, RDI has a worse debt to assets ratio.
RDI Yearly Shares OutstandingRDI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDI Yearly Total Debt VS Total AssetsRDI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.27, we must say that RDI is in the distress zone and has some risk of bankruptcy.
RDI's Altman-Z score of -0.27 is on the low side compared to the rest of the industry. RDI is outperformed by 69.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.27
ROIC/WACCN/A
WACC8.57%
RDI Yearly LT Debt VS Equity VS FCFRDI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

RDI has a Current Ratio of 0.23. This is a bad value and indicates that RDI is not financially healthy enough and could expect problems in meeting its short term obligations.
RDI has a worse Current ratio (0.23) than 88.89% of its industry peers.
A Quick Ratio of 0.22 indicates that RDI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.22, RDI is doing worse than 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.22
RDI Yearly Current Assets VS Current LiabilitesRDI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.20% over the past year.
The Revenue has decreased by -7.40% in the past year.
RDI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.33% yearly.
EPS 1Y (TTM)18.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.41%
Revenue 1Y (TTM)-7.4%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%-19.2%

3.2 Future

Based on estimates for the next years, RDI will show a very strong growth in Earnings Per Share. The EPS will grow by 28.82% on average per year.
The Revenue is expected to grow by 9.94% on average over the next years. This is quite good.
EPS Next Y68.09%
EPS Next 2Y36.19%
EPS Next 3Y28.82%
EPS Next 5YN/A
Revenue Next Year9.3%
Revenue Next 2Y11.24%
Revenue Next 3Y9.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RDI Yearly Revenue VS EstimatesRDI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
RDI Yearly EPS VS EstimatesRDI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDI Price Earnings VS Forward Price EarningsRDI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RDI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 131.65
RDI Per share dataRDI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as RDI's earnings are expected to grow with 28.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.19%
EPS Next 3Y28.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RDI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

READING INTERNATIONAL INC-A

NASDAQ:RDI (8/1/2025, 7:48:24 PM)

After market: 1.24 -0.09 (-6.77%)

1.33

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-18 2025-08-18/bmo
Inst Owners45.34%
Inst Owner Change3.52%
Ins Owners6.51%
Ins Owner Change0.94%
Market Cap29.90M
Analysts80
Price Target2.55 (91.73%)
Short Float %0.56%
Short Ratio3.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.92%
Min EPS beat(2)37.06%
Max EPS beat(2)48.79%
EPS beat(4)2
Avg EPS beat(4)-39.32%
Min EPS beat(4)-128.48%
Max EPS beat(4)48.79%
EPS beat(8)2
Avg EPS beat(8)-412.07%
EPS beat(12)3
Avg EPS beat(12)-293.3%
EPS beat(16)4
Avg EPS beat(16)-231.87%
Revenue beat(2)1
Avg Revenue beat(2)0.97%
Min Revenue beat(2)-7.5%
Max Revenue beat(2)9.43%
Revenue beat(4)1
Avg Revenue beat(4)-6.33%
Min Revenue beat(4)-19.13%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-5.59%
Revenue beat(12)3
Avg Revenue beat(12)-5.44%
Revenue beat(16)4
Avg Revenue beat(16)-5.25%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-354.54%
EPS NY rev (1m)0%
EPS NY rev (3m)19.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 131.65
EPS(TTM)-1.2
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS9.15
BVpS-0.36
TBVpS-1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.43%
FCFM N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 82.92
Cap/Depr 25.78%
Cap/Sales 1.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.22
Altman-Z -0.27
F-Score6
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)34.68%
Cap/Depr(5y)51%
Cap/Sales(3y)3.09%
Cap/Sales(5y)8.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.41%
EPS Next Y68.09%
EPS Next 2Y36.19%
EPS Next 3Y28.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.4%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%-19.2%
Revenue Next Year9.3%
Revenue Next 2Y11.24%
Revenue Next 3Y9.94%
Revenue Next 5YN/A
EBIT growth 1Y-14.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.06%
EBIT Next 3Y60.72%
EBIT Next 5YN/A
FCF growth 1Y61.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.33%
OCF growth 3YN/A
OCF growth 5YN/A